Navigation Links
KV Pharmaceutical Company, Purdue Pharma L.P. Settle OxyContin(R) Dispute
Date:6/9/2009

ch, including the possibility that any product launch may be delayed or that product acceptance may be less than anticipated; (6) reliance on key strategic alliances; (7) the availability of raw materials and/or products manufactured for the Company under contract manufacturing arrangements with third parties; (8) the regulatory environment, including regulatory agency and judicial actions and changes in applicable law or regulations; (9) fluctuations in revenues; (10) the difficulty of predicting international regulatory approval, including timing; (11) the difficulty of predicting the pattern of inventory movements by the Company's customers; (12) the impact of competitive response to the Company's sales, marketing and strategic efforts, including the introduction or potential introduction of generic or competing products against products sold by the Company and its subsidiaries; (13) risks that the Company may not ultimately prevail in litigation, including challenges to the Company's intellectual property rights by actual or potential competitors or to the Company's ability to market generic products due to brand company patents and challenges to other companies' introduction or potential introduction of generic or competing products by third parties against products sold by the Company or its subsidiaries, including without limitation the litigation and claims referred to in Note 16 of the Notes to the Consolidated Financial Statements in the Company's Form 10-Q for the quarter ended June 30, 2008; (14) the possibility that the Company's current estimates of the financial effect of certain announced product recalls could prove to be incorrect; (15) whether any product recalls or product introductions result in litigation, agency action or material damages; (16) the possibility that the findings of the Audit Committee inquiry referenced in the Company's Form 10-Q for the quarter ended June 30, 2008, Form 12b-25 filed with the U.S. Securities and Exchange Commiss
'/>"/>
SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia
2. Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit
3. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
4. Par Pharmaceutical Begins Shipment of Generic Miacalcin(R)
5. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
6. Metastorm Customer, Wyeth Pharmaceuticals, Wins CIO 100 Award for BPM Project
7. Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference
8. Isis Pharmaceuticals to Present at Needhams 8th Annual Life Sciences Conference
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009
10. Elsevier to Create New Guidelines for Pharmaceutical Article Reprint, Compilation and Custom Publications
11. Anadys Pharmaceuticals, Inc. Announces Pricing of Common Stock and Warrant Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 (HealthDay ... phenomenon is when an illness that originated in animals jumps ... -- is not uncommon and keeps researchers on their toes ... make inroads into the human population. A new report ... in this case were guinea pigs. More specifically, they were ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 ... overall health, but a growing body of evidence shows the ... finds. In fact, the benefits were similar to those ... Paula Chu, a doctoral candidate at Harvard University,s Health Policy ... found that people randomly assigned to take yoga classes saw ...
(Date:12/15/2014)... Main Street Dental Team ( http://www.MainStreetDentalTeam.com ), ... a new study providing evidence on the impact of ... children. , Sufficient enough evidence already exists showing a ... juice drinks, with the onset of tooth decay. One ... listed as 100% fruit juice, meaning it is completely ...
(Date:12/15/2014)... HealthDay Reporter FRIDAY, Dec. 12, 2014 (HealthDay ... of American women who have migraine: The debilitating headaches don,t ... association between migraine and breast cancer risk," said lead researcher ... School. "There is no positive association, so there is no ... About 18 percent of American women and 6 percent ...
(Date:12/15/2014)... OR (PRWEB) December 15, 2014 ... seeks to bring attention to restrictive state laws ... position paper on this important area of public ... Laws Can Compromise the Integrity of Independent Review, ... and access of independent peer review determinations can ...
Breaking Medicine News(10 mins):Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2
... 20 Environmental Tectonics Corporation,s (Amex: ETC ) ... the Life Support Technologies (LST), a wound care management group ... two BARA-MED(R) XD monoplace hyperbaric chambers in Good Samaritan Hospital. ... is the management group selected by Good Samaritan Hospital - ...
... Today, Natural,Nutrition, Inc. (OTC Bulletin Board: NTNI) ( www.naturalnutritioninc.com ... nine months of,2008 through September 30th versus losses of ... These numbers are unaudited and subject to revision.,The details ... of 2008 may,be found in the Company,s recently filed ...
... less guilt is easy this holiday season. Simply substitute canola oil ... saturated fat with "nice" unsaturated fat. This especially applies to baking, ... , Use canola oil in recipes that call for ... muffins, says Shirley Corriher, author of the new BakeWise ...
... simulation technology ever held, will feature cutting-edge medical simulations ranging ... and management on December 1-4 at the Orange County Convention ... ... Orlando, FL (Vocus) November 20, 2008 -- I/ITSEC, The largest ...
... received ISO 9001:2000 and ISO 13485:2003 certification for its Enfield Connecticut ... quality system for contract moulding of PEKK parts, manufacture of PEKK ... was issued by TUV USA Inc. and is valid until October ... ...
... Growth in Sales and Considerable Improvement in Profit and,Margins; Cash Flow Doubled; Earnings per Share ... Quarter Grew 36.9% to US$ 120 M, - Gross Profit Grew by ... US$ 15 M, - EBITDA Grew by 74.1% to US$ 20 M, ... - Cash Flow From Current Activities Grew by 140% to US$12.6 M, ...
Cached Medicine News:Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces Additional Sales of its Baramed Monoplace Chambers 2Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces Additional Sales of its Baramed Monoplace Chambers 3Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces Additional Sales of its Baramed Monoplace Chambers 4Health News:Natural Nutrition Reports Comprehensive Income of $2,062,452 Through Third Quarter, 2008 2Health News:Baking Expert Puts Health in the Holidays With Canola Oil 2Health News:Medical Technology to be Highlighted at World's Largest Simulation Exhibition 2Health News:Oxford Performance Materials Received ISO 13485 and ISO 9001 Certification 2Health News:Frutarom Continues to Implement its Rapid Growth Strategy 2Health News:Frutarom Continues to Implement its Rapid Growth Strategy 3Health News:Frutarom Continues to Implement its Rapid Growth Strategy 4Health News:Frutarom Continues to Implement its Rapid Growth Strategy 5
(Date:12/15/2014)... BRIDGEWATER, N.J. , Dec. 15, 2014   ... SAN and NYSE: SNY) are collaborating with nationally-recognized patient ... Counts , an awareness program that will gauge how ... risks associated with high LDL-C (bad cholesterol).  American adults ... to take a brief poll and answer a few ...
(Date:12/15/2014)... --  DaVita HealthCare Partners Inc.  (NYSE: ... most innovative health care communities, today announced that ... Research  (DCR) and  HealthCare Partners Clinical Research , will ... research and data analytics services, specifically in patients ... disease (ESRD), as well as primary care and ...
(Date:12/13/2014)... December 12, 2014 ... the addition of the  "Global Catheters Market ... Global Trends, Company Profiles, Analysis, Segmentation and ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... up of medical grade material such as ...
Breaking Medicine Technology:Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 3Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 5Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 6DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4Global Catheters Market (Product Types and Geography) - Forecast to 2020 2Global Catheters Market (Product Types and Geography) - Forecast to 2020 3
... Uroplasty, Inc. (NASDAQ: UPI ), a medical device ... treat voiding dysfunctions, announced today that its President and CEO ... on Tuesday, June 7, 2011.  The ceremony, held at the ... be broadcast live beginning at 3:45 p.m. ET via the ...
... 6, 2011 University Hospitals (UH) Seidman Cancer ... hospital, opens to patients on June 6. The ... cancer-fighting treatments and technology – all in a ... ) The $260 million, 375,000-square-foot ...
Cached Medicine Technology:Uroplasty's Dave Kaysen to Ring NASDAQ Closing Bell 2University Hospitals Seidman Cancer Center Opens: First Cancer Hospital in Northeast Ohio Offers Nation's Most Advanced Technology and Treatments 2University Hospitals Seidman Cancer Center Opens: First Cancer Hospital in Northeast Ohio Offers Nation's Most Advanced Technology and Treatments 3
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: